共 48 条
- [41] „Drug-coated-Stent“ bei Patienten mit hohem Blutungsrisiko dem „Bare‑metal‑Stent“ überlegenZwei-Jahres-Ergebnisse der LEADERS‑FREE‑StudieDrug-coated stents superior to bare metal stents in patients with high risk of bleedingTwo-year results of the LEADERS FREE study Der Kardiologe, 2017, 11 (3): : 148 - 150
- [44] Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy AMERICAN HEART JOURNAL, 2013, 165 (05) : 704 - 709
- [47] Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute Myocardial Infarction Registry CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (07) : 1264 - 1275
- [48] Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitusResults of the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol- and Zotarolimus-Eluting Stents (ISAR-TEST 5) trial Clinical Research in Cardiology, 2021, 110 : 1586 - 1598